Key statistics
On Thursday, Prime Medicine Inc (PRME:NMQ) closed at 3.91, 12.68% above the 52 week low of 3.47 set on Sep 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.16 |
---|---|
High | 4.19 |
Low | 3.89 |
Bid | 3.87 |
Offer | 4.08 |
Previous close | 3.98 |
Average volume | 678.79k |
---|---|
Shares outstanding | 120.03m |
Free float | 88.50m |
P/E (TTM) | -- |
Market cap | 477.72m USD |
EPS (TTM) | -2.16 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
- Prime Medicine to Participate in Upcoming Investor Conferences
- Prime Medicine Reports Second Quarter 2024 Financial Results and Provides Business Updates
- Prime Medicine to Present at Upcoming Investor Conferences
- Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
- Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates
- Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)
- Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference
- Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
- Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
- Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
More ▼